Velcade
Term · Oncology and biomedicine · MLC-T-ONC-009204
A drug used to treat adults with multiple myeloma or mantle cell lymphoma. It is also being studied in the treatment of other types of cancer. Velcade blocks the action of enzymes called proteasomes, which may help keep cancer cells from growing and may kill them. It is a type of proteasome inhibitor. Also called bortezomib and PS-341.
| Identifier | MLC-T-ONC-009204 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | bortezomib; PS-341 |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-009204",
"term": "Velcade",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat adults with multiple myeloma or mantle cell lymphoma. It is also being studied in the treatment of other types of cancer. Velcade blocks the action of enzymes called proteasomes, which may help keep cancer cells from growing and may kill them. It is a type of proteasome inhibitor. Also called bortezomib and PS-341.",
"synonyms": [
"bortezomib",
"PS-341"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/velcade/"
}
Record 17,178 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.